Anaesthetic drugs & techniques

Contact heat evoked potentials as a measure of the analgesic component of anesthesia – a patient study

J Clin Monit ComputPublished Randomised controlled trial

Authors' conclusion

CHEPs monitoring appears unsuitable for direct assessment of the analgesic component of general anesthesia.

Study context

Population
Adult ASA I or II patients; heat stimulus 20% above individual pain threshold to volar forearm119 analysed
Participants
120 participants
Comparison
Remifentanil at 0.05, 0.1, 0.2 or 0.4 μg/kg/min; then propofol to loss of responsiveness
Primary endpoint
(1) Correlation between remifentanil-induced changes in VAS and CHEP amplitudes; (2) correlation between CHEP amplitude reduction and remifentanil infusion rate
Methodological detailsdose-response, four infusion rates
  • Dose-response
  • Four infusion rates

Primary result

As reported in the abstract

Correlation visual analog scale (VAS) vs CHEP amplitudes (not significant)

r=−0.17; p=0.868

Correlation remifentanil dosage vs CHEP amplitudes

r=0.29; p=0.003

Further findings

Remifentanil dosage vs VAS

Strong inverse correlation
r=−0.46; p<0.001

Sedation (OAA/S score and middle latency auditory evoked potentials (MLAEPs))

Correlation between remifentanil dosage and degree of sedation

Contact heat evoked potentials (CHEPs) after propofol-induced loss of responsiveness

CHEPs no longer detectable

Original publication

Contact heat evoked potentials as a measure of the analgesic component of anesthesia – a patient study. J Clin Monit Comput. Published 17 September 2026. doi:10.1007/s10877-026-01501-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.